Abstract | UNLABELLED: CONCLUSION:
Hyponatremia is a potential adverse effect in patients with nocturnal enuresis who are treated with DDAVP. To prevent this adverse effect we recommend that the patients prescribed DDAVP for nocturnal enuresis should be counseled not to ingest more than 240 ml (8 ounces) of fluid on any night that DDAVP is administered.
|
Authors | W L Robson, J P Nørgaard, A K Leung |
Journal | European journal of pediatrics
(Eur J Pediatr)
Vol. 155
Issue 11
Pg. 959-62
(Nov 1996)
ISSN: 0340-6199 [Print] Germany |
PMID | 8911897
(Publication Type: Journal Article, Review)
|
Chemical References |
- Renal Agents
- Deamino Arginine Vasopressin
|
Topics |
- Adolescent
- Child
- Child, Preschool
- Deamino Arginine Vasopressin
(adverse effects)
- Enuresis
(drug therapy)
- Humans
- Hyponatremia
(chemically induced)
- Renal Agents
(adverse effects)
|